ADAR1 Capital Management
Latest statistics and disclosures from ADAR1 Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are ABVX, PTGX, ROIV, IMVT, RNA, and represent 32.77% of ADAR1 Capital Management's stock portfolio.
- Added to shares of these 10 stocks: RNA (+$36M), TERN (+$22M), CLDX (+$15M), IVA (+$13M), ABUS (+$12M), FULC (+$10M), TFX (+$9.8M), IWM (+$9.7M), CDTX (+$8.4M), CBIO (+$7.2M).
- Started 81 new stock positions in KYTX, ACET, BCRX, ELDN, JBIO, IVF, TFX, VERU, TRAW, IVA.
- Reduced shares in these 10 stocks: KROS (-$109M), ETNB (-$31M), SPY (-$31M), BIOA (-$23M), IVVD (-$8.6M), MTSR (-$8.0M), SRPT (-$6.9M), VRNA (-$5.5M), VKTX (-$5.3M), BBIO.
- Sold out of its positions in AKRO, ALMS, AVTX, Biomx, Bridgebio Pharma, Bridgebio Pharma, SAVA, DAWN, ETNB, Intelligent Bio Solutions In.
- ADAR1 Capital Management was a net buyer of stock by $49M.
- ADAR1 Capital Management has $1.4B in assets under management (AUM), dropping by 27.90%.
- Central Index Key (CIK): 0001940272
Tip: Access up to 7 years of quarterly data
Positions held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for ADAR1 Capital Management
ADAR1 Capital Management holds 256 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Abivax Sa Sponsored Ads (ABVX) | 13.0 | $178M | -2% | 1.3M | 134.85 |
|
| Protagonist Therapeutics (PTGX) | 6.7 | $92M | +6% | 1.0M | 87.34 |
|
| Roivant Sciences SHS (ROIV) | 5.5 | $74M | +2% | 3.4M | 21.70 |
|
| Immunovant (IMVT) | 4.6 | $63M | +10% | 2.5M | 25.42 |
|
| Avidity Biosciences Ord (RNA) | 2.9 | $39M | +918% | 547k | 72.13 |
|
| Ea Series Trust Alpha Arch 1-3 (BOXX) | 2.8 | $39M | 337k | 115.10 |
|
|
| Spdr S&p 500 Etf Tr Tr Unit (SPY) | 2.7 | $37M | -45% | 55k | 681.92 |
|
| Cytokinetics Com New (CYTK) | 2.5 | $34M | +4% | 540k | 63.54 |
|
| Septerna (SEPN) | 2.4 | $32M | 1.2M | 27.88 |
|
|
| Arbutus Biopharma (ABUS) | 1.9 | $26M | +86% | 5.4M | 4.81 |
|
| Zai Lab Adr (ZLAB) | 1.6 | $22M | +43% | 1.2M | 17.64 |
|
| Terns Pharmaceuticals (TERN) | 1.6 | $22M | +5316% | 542k | 40.40 |
|
| Cytomx Therapeutics (CTMX) | 1.3 | $18M | +5% | 4.3M | 4.26 |
|
| Celldex Therapeutics Com New (CLDX) | 1.3 | $18M | +490% | 647k | 27.16 |
|
| Rapt Therapeutics Com New (RAPT) | 1.3 | $17M | 510k | 33.87 |
|
|
| Inhibikase Therapeutics Com New (IKT) | 1.2 | $17M | +53% | 8.1M | 2.05 |
|
| Bridgebio Pharma (BBIO) | 1.2 | $16M | -21% | 213k | 76.49 |
|
| Monopar Therapeutics Com New (MNPR) | 1.1 | $15M | +79% | 234k | 65.30 |
|
| Fulcrum Therapeutics (FULC) | 1.1 | $15M | +216% | 1.3M | 11.31 |
|
| Vaxcyte (PCVX) | 1.1 | $15M | +48% | 316k | 46.14 |
|
| Crinetics Pharmaceuticals In (CRNX) | 1.1 | $14M | +24% | 309k | 46.55 |
|
| Prothena Corp SHS (PRTA) | 1.0 | $14M | 1.5M | 9.55 |
|
|
| Lexeo Therapeutics (LXEO) | 1.0 | $14M | -9% | 1.4M | 9.93 |
|
| Taysha Gene Therapies Com Shs (TSHA) | 1.0 | $14M | -11% | 2.5M | 5.50 |
|
| Cidara Therapeutics Com New (CDTX) | 1.0 | $13M | +177% | 60k | 220.89 |
|
| Inventiva Sa Ads (IVA) | 0.9 | $13M | NEW | 2.7M | 4.65 |
|
| Establishment Labs Holdings Ord (ESTA) | 0.9 | $13M | +89% | 171k | 72.88 |
|
| Spdr Series Trust State Street Spd (BIL) | 0.9 | $12M | 136k | 91.38 |
|
|
| Replimune Group (REPL) | 0.9 | $12M | +23% | 1.3M | 9.72 |
|
| Ionis Pharmaceuticals (IONS) | 0.9 | $12M | +9% | 147k | 79.11 |
|
| Revolution Medicines (RVMD) | 0.8 | $12M | +4% | 145k | 79.65 |
|
| Amylyx Pharmaceuticals (AMLX) | 0.8 | $11M | +2% | 890k | 12.08 |
|
| Cg Oncology (CGON) | 0.8 | $11M | +3% | 258k | 41.52 |
|
| Aa Mission Acquisition Corp Ord Shs Cl A | 0.8 | $11M | 983k | 10.67 |
|
|
| Teleflex Incorporated (TFX) | 0.7 | $9.8M | NEW | 81k | 122.04 |
|
| Ishares Tr Russell 2000 Etf Put Option (IWM) | 0.7 | $9.7M | NEW | 40k | 246.16 |
|
| Adagio Therapeutics (IVVD) | 0.7 | $9.6M | -47% | 3.9M | 2.47 |
|
| Regeneron Pharmaceuticals (REGN) | 0.7 | $9.3M | -23% | 12k | 771.87 |
|
| Xenon Pharmaceuticals (XENE) | 0.7 | $9.1M | +7% | 204k | 44.82 |
|
| Equillium (EQ) | 0.6 | $8.7M | 5.6M | 1.55 |
|
|
| Savara (SVRA) | 0.6 | $8.5M | -29% | 1.4M | 6.03 |
|
| Maze Therapeatics (MAZE) | 0.5 | $7.4M | +589% | 180k | 41.43 |
|
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 0.5 | $7.4M | -11% | 236k | 31.21 |
|
| Crescent Biopharma (CBIO) | 0.5 | $7.2M | NEW | 606k | 11.86 |
|
| Ovid Therapeutics (OVID) | 0.5 | $7.0M | +33256% | 4.3M | 1.63 |
|
| Belite Bio Sponsored Ads (BLTE) | 0.5 | $6.4M | NEW | 40k | 159.96 |
|
| Uniqure Nv SHS (QURE) | 0.5 | $6.3M | -20% | 265k | 23.93 |
|
| Vertex Pharmaceuticals Incorporated (VRTX) | 0.5 | $6.2M | +95% | 14k | 453.36 |
|
| Brighthouse Finl (BHF) | 0.5 | $6.2M | +855% | 96k | 64.79 |
|
| Anteris Technologies Global (AVR) | 0.5 | $6.2M | +526% | 1.2M | 4.99 |
|
| Protara Therapeutics Com Stk (TARA) | 0.4 | $6.1M | +3127% | 1.1M | 5.33 |
|
| Perceptive Cap Solutions Cor Cl A Ord Shs (PCSC) | 0.4 | $6.0M | -39% | 457k | 13.03 |
|
| Danaher Corporation (DHR) | 0.4 | $5.9M | NEW | 26k | 228.92 |
|
| Eliem Therapeutics (CLYM) | 0.4 | $5.7M | +972% | 1.4M | 4.00 |
|
| Rhythm Pharmaceuticals (RYTM) | 0.4 | $5.5M | +3% | 51k | 107.04 |
|
| Oaktree Acquisition Corp Iii Unit 10/04/2029 (OACCU) | 0.4 | $5.5M | 517k | 10.62 |
|
|
| Ascendis Pharma A/s Sponsored Adr (ASND) | 0.4 | $5.4M | -30% | 25k | 213.24 |
|
| Agios Pharmaceuticals (AGIO) | 0.4 | $5.1M | +408% | 188k | 27.22 |
|
| Spruce Biosciences Com New (SPRB) | 0.4 | $5.1M | NEW | 58k | 87.11 |
|
| Mineralys Therapeutics (MLYS) | 0.4 | $4.9M | +74% | 136k | 36.29 |
|
| Krystal Biotech (KRYS) | 0.4 | $4.9M | +8% | 20k | 246.54 |
|
| Palisade Bio (PALI) | 0.3 | $4.7M | NEW | 2.0M | 2.35 |
|
| Silverback Therapeutics (SPRY) | 0.3 | $4.3M | +523% | 370k | 11.65 |
|
| Biogen Idec (BIIB) | 0.3 | $4.3M | +35% | 24k | 175.99 |
|
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 0.3 | $4.2M | +3% | 119k | 35.08 |
|
| American Exceptionalism Acqu Ord Cl A (AEXA) | 0.3 | $4.1M | +615% | 358k | 11.39 |
|
| Urogen Pharma (URGN) | 0.3 | $3.9M | +120% | 165k | 23.42 |
|
| Arrowhead Pharmaceuticals (ARWR) | 0.3 | $3.9M | +16% | 58k | 66.39 |
|
| Atai Beckley Nv SHS | 0.3 | $3.7M | 913k | 4.09 |
|
|
| Corvus Pharmaceuticals (CRVS) | 0.3 | $3.6M | NEW | 466k | 7.70 |
|
| Janux Therapeutics (JANX) | 0.2 | $3.4M | -30% | 246k | 13.80 |
|
| Monte Rosa Therapeutics (GLUE) | 0.2 | $3.4M | 216k | 15.68 |
|
|
| Avadel Pharmaceuticals Com Shs (AVDL) | 0.2 | $3.2M | NEW | 151k | 21.55 |
|
| Contineum Therapeutics Cl A (CTNM) | 0.2 | $3.2M | +257% | 279k | 11.43 |
|
| Evommune Com Shs (EVMN) | 0.2 | $3.2M | NEW | 184k | 17.12 |
|
| Fractyl Health Call Option (GUTS) | 0.2 | $3.1M | +10807% | 1.4M | 2.20 |
|
| Sanofi Sa Sponsored Adr (SNY) | 0.2 | $3.1M | -14% | 64k | 48.46 |
|
| Scholar Rock Hldg Corp (SRRK) | 0.2 | $3.1M | +246% | 70k | 44.05 |
|
| Nektar Therapeutics Com New (NKTR) | 0.2 | $3.0M | 72k | 42.28 |
|
|
| Zura Bio Class A Ord Shs (ZURA) | 0.2 | $2.9M | -13% | 562k | 5.24 |
|
| Onkure Therapeutics Com Cl A (OKUR) | 0.2 | $2.9M | NEW | 1.0M | 2.90 |
|
| Athira Pharma | 0.2 | $2.9M | NEW | 394k | 7.34 |
|
| Bridgebio Oncology Therapeut Com New (BBOT) | 0.2 | $2.8M | -54% | 226k | 12.52 |
|
| Eledon Pharmaceuticals (ELDN) | 0.2 | $2.8M | NEW | 1.8M | 1.51 |
|
| Engene Holdings (ENGN) | 0.2 | $2.7M | NEW | 304k | 9.03 |
|
| Inovio Pharmaceuticals Com Shs (INO) | 0.2 | $2.7M | NEW | 1.6M | 1.74 |
|
| Dynavax Technologies Corp Com New (DVAX) | 0.2 | $2.6M | 170k | 15.38 |
|
|
| Miragen Therapeutics (VRDN) | 0.2 | $2.4M | -24% | 77k | 31.12 |
|
| Pharvaris N V (PHVS) | 0.2 | $2.4M | +150% | 86k | 27.75 |
|
| Corbus Pharmaceuticals Hldgs Com New (CRBP) | 0.2 | $2.3M | +2711% | 287k | 8.14 |
|
| Astria Therapeutics | 0.2 | $2.3M | -10% | 174k | 13.09 |
|
| Delcath Sys Com New (DCTH) | 0.2 | $2.3M | 224k | 10.10 |
|
|
| Edgewise Therapeutics (EWTX) | 0.2 | $2.3M | +127% | 91k | 24.82 |
|
| Acasti Pharma (GRCE) | 0.2 | $2.2M | +83% | 642k | 3.46 |
|
| Gossamer Bio (GOSS) | 0.2 | $2.2M | +165% | 711k | 3.10 |
|
| Regenxbio Inc equity us cm (RGNX) | 0.2 | $2.1M | -29% | 145k | 14.40 |
|
| Arcellx Common Stock (ACLX) | 0.2 | $2.1M | 32k | 65.20 |
|
|
| Olema Pharmaceuticals (OLMA) | 0.1 | $2.0M | +33% | 81k | 25.00 |
|
| Masimo Corporation (MASI) | 0.1 | $2.0M | 15k | 130.06 |
|
|
| Cybin Com New (HELP) | 0.1 | $2.0M | +616% | 238k | 8.18 |
|
| Soleno Therapeutics (SLNO) | 0.1 | $1.9M | +65% | 42k | 46.30 |
|
| Acumen Pharmaceuticals (ABOS) | 0.1 | $1.9M | 891k | 2.11 |
|
|
| Aclaris Therapeutics (ACRS) | 0.1 | $1.8M | +64% | 614k | 3.01 |
|
| Pfizer (PFE) | 0.1 | $1.8M | +63% | 72k | 24.90 |
|
| Bioage Labs (BIOA) | 0.1 | $1.8M | -92% | 136k | 13.23 |
|
| Alkermes SHS (ALKS) | 0.1 | $1.8M | +13% | 64k | 27.98 |
|
| Globus Med Cl A (GMED) | 0.1 | $1.8M | NEW | 20k | 87.31 |
|
| Alector (ALEC) | 0.1 | $1.7M | NEW | 1.1M | 1.56 |
|
| Omeros Corporation Put Option (OMER) | 0.1 | $1.7M | NEW | 100k | 17.18 |
|
| Rocket Pharmaceuticals (RCKT) | 0.1 | $1.7M | -17% | 476k | 3.51 |
|
| Ww Intl Com New (WW) | 0.1 | $1.7M | +8% | 57k | 29.21 |
|
| Aquestive Therapeutics Put Option (AQST) | 0.1 | $1.6M | NEW | 254k | 6.46 |
|
| Summit Therapeutics (SMMT) | 0.1 | $1.6M | -10% | 92k | 17.49 |
|
| Cohen Circle Acquisit Corp I Unit 07/01/2030 (CCIIU) | 0.1 | $1.6M | 150k | 10.43 |
|
|
| Supernus Pharmaceuticals (SUPN) | 0.1 | $1.5M | +106% | 30k | 49.70 |
|
| Inspire Med Sys (INSP) | 0.1 | $1.4M | +150% | 15k | 92.23 |
|
| Nurix Therapeutics (NRIX) | 0.1 | $1.4M | +130% | 72k | 18.97 |
|
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 0.1 | $1.4M | +220% | 8.0k | 170.00 |
|
| Omniab (OABI) | 0.1 | $1.3M | -35% | 702k | 1.85 |
|
| Tango Therapeutics (TNGX) | 0.1 | $1.2M | NEW | 140k | 8.86 |
|
| Adagio Med Hldgs (ADGM) | 0.1 | $1.2M | NEW | 1.2M | 1.04 |
|
| Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA) | 0.1 | $1.2M | -61% | 29k | 41.25 |
|
| Spyre Therapeutics Com New (SYRE) | 0.1 | $1.1M | 34k | 32.76 |
|
|
| Adicet Bio Com New (ACET) | 0.1 | $1.1M | NEW | 129k | 8.42 |
|
| Bristol Myers Squibb (BMY) | 0.1 | $1.1M | NEW | 20k | 53.94 |
|
| Tenaya Therapeutics (TNYA) | 0.1 | $1.1M | NEW | 1.5M | 0.71 |
|
| Dyne Therapeutics (DYN) | 0.1 | $1.0M | -8% | 53k | 19.56 |
|
| Best Spac I Acquisition Corp Unit 05/27/2030 (BSAAU) | 0.1 | $1.0M | 100k | 10.24 |
|
|
| Merck & Co (MRK) | 0.1 | $1.0M | -48% | 9.6k | 105.26 |
|
| Churchill Cap Corp X Shs Cl A (CCCX) | 0.1 | $1.0M | NEW | 65k | 15.60 |
|
| Electronic Arts (EA) | 0.1 | $1.0M | 4.9k | 204.33 |
|
|
| McKesson Corporation (MCK) | 0.1 | $984k | NEW | 1.2k | 820.29 |
|
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.1 | $965k | -28% | 39k | 25.01 |
|
| Biontech Se Sponsored Ads (BNTX) | 0.1 | $952k | 10k | 95.20 |
|
|
| Viking Therapeutics (VKTX) | 0.1 | $932k | -84% | 27k | 35.18 |
|
| United Therapeutics Corporation (UTHR) | 0.1 | $926k | -83% | 1.9k | 487.25 |
|
| Plymouth Indl Reit | 0.1 | $899k | NEW | 41k | 21.88 |
|
| Keen Vision Acquisition Corp SHS Call Option (KVAC) | 0.1 | $881k | 75k | 11.75 |
|
|
| 4d Molecular Therapeutics In (FDMT) | 0.1 | $875k | +598% | 117k | 7.50 |
|
| Denali Therapeutics (DNLI) | 0.1 | $860k | 52k | 16.51 |
|
|
| Xencor (XNCR) | 0.1 | $860k | -56% | 56k | 15.31 |
|
| Liquidia Corporation Com New Put Option (LQDA) | 0.1 | $845k | NEW | 25k | 34.49 |
|
| Kalaris Therapeutics (KLRS) | 0.1 | $844k | NEW | 100k | 8.44 |
|
| Quoin Pharmaceuticals Sponsored Ads (QNRX) | 0.1 | $840k | NEW | 58k | 14.43 |
|
| Astrazeneca Sponsored Adr | 0.1 | $827k | NEW | 9.0k | 91.93 |
|
| Gilead Sciences (GILD) | 0.1 | $818k | NEW | 6.7k | 122.74 |
|
| Avantor (AVTR) | 0.1 | $802k | +180% | 70k | 11.46 |
|
| Alexandria Real Estate Equities (ARE) | 0.1 | $798k | NEW | 16k | 48.94 |
|
| Pulmonx Corp (LUNG) | 0.1 | $786k | +65% | 355k | 2.21 |
|
| Ibio Com New (IBIO) | 0.1 | $783k | +1401% | 406k | 1.93 |
|
| Tenax Therapeutics Com New (TENX) | 0.1 | $776k | +19% | 64k | 12.19 |
|
| Sutro Biopharma Com Shs (STRO) | 0.1 | $776k | NEW | 67k | 11.57 |
|
| BioMarin Pharmaceutical (BMRN) | 0.1 | $767k | +163% | 13k | 59.43 |
|
| Compass Therapeutics (CMPX) | 0.1 | $746k | +178% | 139k | 5.37 |
|
| Vera Therapeutics Cl A (VERA) | 0.1 | $746k | NEW | 15k | 50.64 |
|
| Kezar Life Sciences Com New (KZR) | 0.1 | $739k | -6% | 117k | 6.29 |
|
| Ventyx Biosciences (VTYX) | 0.1 | $737k | 82k | 9.03 |
|
|
| Guardant Health (GH) | 0.1 | $715k | +16% | 7.0k | 102.14 |
|
| Phathom Pharmaceuticals (PHAT) | 0.1 | $712k | 43k | 16.59 |
|
|
| Larimar Therapeutics (LRMR) | 0.1 | $708k | -21% | 186k | 3.81 |
|
| Ideaya Biosciences (IDYA) | 0.1 | $691k | 20k | 34.57 |
|
|
| Arvinas Ord (ARVN) | 0.1 | $689k | -29% | 58k | 11.86 |
|
| Nuvalent Inc-a (NUVL) | 0.1 | $688k | -42% | 6.8k | 100.59 |
|
| Assembly Biosciences Com New (ASMB) | 0.0 | $672k | +4% | 20k | 34.01 |
|
| Forward Air Corp (FWRD) | 0.0 | $666k | NEW | 27k | 25.00 |
|
| Enanta Pharmaceuticals (ENTA) | 0.0 | $652k | NEW | 41k | 15.77 |
|
| Oruka Therapeutics (ORKA) | 0.0 | $632k | 21k | 30.31 |
|
|
| Neurogene (NGNE) | 0.0 | $631k | 31k | 20.60 |
|
|
| Tectonic Therapeutic (TECX) | 0.0 | $626k | -46% | 30k | 20.86 |
|
| Sarepta Therapeutics (SRPT) | 0.0 | $621k | -91% | 29k | 21.52 |
|
| Intuitive Surgical Com New (ISRG) | 0.0 | $578k | NEW | 1.0k | 566.36 |
|
| Kyverna Therapeutics (KYTX) | 0.0 | $540k | NEW | 57k | 9.40 |
|
| Alibaba Group Hldg Sponsored Ads (BABA) | 0.0 | $525k | 3.6k | 146.58 |
|
|
| Madrigal Pharmaceuticals (MDGL) | 0.0 | $521k | -81% | 895.00 | 582.34 |
|
| Cullinan Oncology (CGEM) | 0.0 | $518k | NEW | 50k | 10.35 |
|
| Context Therapeutics (CNTX) | 0.0 | $516k | 351k | 1.47 |
|
|
| Globa Terra Acquisition Cor Unit 99/99/9999 (GTERU) | 0.0 | $514k | 50k | 10.28 |
|
|
| Wisdomtree Tr Floatng Rat Trea (USFR) | 0.0 | $503k | 10k | 50.32 |
|
|
| Apellis Pharmaceuticals (APLS) | 0.0 | $502k | 20k | 25.12 |
|
|
| Vistagen Therapeutics Ord (VTGN) | 0.0 | $492k | +557% | 744k | 0.66 |
|
| Natera (NTRA) | 0.0 | $492k | NEW | 2.1k | 229.09 |
|
| Boston Scientific Corporation (BSX) | 0.0 | $477k | NEW | 5.0k | 95.35 |
|
| Enliven Therapeutics (ELVN) | 0.0 | $462k | NEW | 30k | 15.40 |
|
| Elanco Animal Health (ELAN) | 0.0 | $453k | NEW | 20k | 22.63 |
|
| Polypid (PYPD) | 0.0 | $451k | NEW | 104k | 4.34 |
|
| Geron Corporation (GERN) | 0.0 | $444k | -26% | 336k | 1.32 |
|
| Praxis Precision Medicines I Com New (PRAX) | 0.0 | $442k | NEW | 1.5k | 294.74 |
|
| Novocure Ord Shs (NVCR) | 0.0 | $440k | -46% | 34k | 12.93 |
|
| Core Scientific (CORZ) | 0.0 | $437k | NEW | 30k | 14.56 |
|
| Kura Oncology (KURA) | 0.0 | $416k | -27% | 40k | 10.39 |
|
| Cortexyme (QNCX) | 0.0 | $412k | -84% | 123k | 3.35 |
|
| Biohaven (BHVN) | 0.0 | $387k | -30% | 34k | 11.29 |
|
| Keros Therapeutics (KROS) | 0.0 | $384k | -99% | 19k | 20.36 |
|
| Karyopharm Therapeutics Com New (KPTI) | 0.0 | $368k | +100% | 50k | 7.36 |
|
| Orthopediatrics Corp. (KIDS) | 0.0 | $352k | NEW | 20k | 17.76 |
|
| BioCryst Pharmaceuticals (BCRX) | 0.0 | $351k | NEW | 45k | 7.80 |
|
| Aurinia Pharmaceuticals (AUPH) | 0.0 | $351k | NEW | 22k | 15.95 |
|
| Ceridian Hcm Hldg | 0.0 | $346k | -50% | 5.0k | 69.16 |
|
| Therapeuticsmd Com New (TXMD) | 0.0 | $341k | 209k | 1.63 |
|
|
| Kiora Pharmaceuticals (KPRX) | 0.0 | $331k | 168k | 1.97 |
|
|
| Jade Biosciences Com New (JBIO) | 0.0 | $324k | NEW | 21k | 15.43 |
|
| Surgery Partners (SGRY) | 0.0 | $309k | 20k | 15.45 |
|
|
| Jd.com Spon Ads Cl A (JD) | 0.0 | $287k | 10k | 28.70 |
|
|
| Procap Acquisition Corp Unit 05/16/2030 (PCAPU) | 0.0 | $276k | 27k | 10.24 |
|
|
| Bright Minds Biosciences Com New (DRUG) | 0.0 | $273k | NEW | 3.5k | 78.04 |
|
| IDEXX Laboratories (IDXX) | 0.0 | $271k | NEW | 400.00 | 676.53 |
|
| Spero Therapeutics (SPRO) | 0.0 | $265k | 114k | 2.33 |
|
|
| Perspective Therapeutics Com New (CATX) | 0.0 | $262k | NEW | 95k | 2.75 |
|
| Immix Biopharma (IMMX) | 0.0 | $262k | NEW | 50k | 5.23 |
|
| Jasper Therapeutics Com New (JSPR) | 0.0 | $256k | NEW | 140k | 1.83 |
|
| Syndax Pharmaceuticals (SNDX) | 0.0 | $252k | NEW | 12k | 21.01 |
|
| Organon & Co Common Stock (OGN) | 0.0 | $251k | +250% | 35k | 7.17 |
|
| Annexon (ANNX) | 0.0 | $241k | NEW | 48k | 5.02 |
|
| Pepgen (PEPG) | 0.0 | $240k | 37k | 6.51 |
|
|
| Evolus (EOLS) | 0.0 | $239k | NEW | 36k | 6.65 |
|
| Achieve Life Sciences (ACHV) | 0.0 | $238k | 48k | 4.97 |
|
|
| Bicara Therapeutics (BCAX) | 0.0 | $231k | 14k | 16.83 |
|
|
| Ultragenyx Pharmaceutical Call Option (RARE) | 0.0 | $230k | +11% | 10k | 23.00 |
|
| Rxsight (RXST) | 0.0 | $227k | NEW | 22k | 10.42 |
|
| Milestone Pharmaceuticals (MIST) | 0.0 | $202k | NEW | 100k | 2.02 |
|
| Aadi Bioscience (WHWK) | 0.0 | $188k | NEW | 78k | 2.42 |
|
| Traws Pharma Com New (TRAW) | 0.0 | $175k | NEW | 154k | 1.13 |
|
| Kalvista Pharmaceuticals (KALV) | 0.0 | $162k | 10k | 16.15 |
|
|
| Outlook Therapeutics Put Option (OTLK) | 0.0 | $158k | NEW | 100k | 1.58 |
|
| Relmada Therapeutics (RLMD) | 0.0 | $149k | NEW | 31k | 4.83 |
|
| Vyne Therapeutics (VYNE) | 0.0 | $147k | NEW | 254k | 0.58 |
|
| Silence Therapeutics Ads (SLN) | 0.0 | $144k | +26% | 24k | 6.08 |
|
| Recursion Pharmaceuticals In Cl A (RXRX) | 0.0 | $143k | 35k | 4.09 |
|
|
| Voyager Therapeutics (VYGR) | 0.0 | $138k | 35k | 3.93 |
|
|
| Cleancore Solutions Class B Com Shs (ZONE) | 0.0 | $136k | NEW | 522k | 0.26 |
|
| Chemomab Therapeutics Sponsored Ads (CMMB) | 0.0 | $132k | NEW | 80k | 1.65 |
|
| Pmv Pharmaceuticals (PMVP) | 0.0 | $126k | 101k | 1.25 |
|
|
| Generation Bio Com New (GBIO) | 0.0 | $126k | 22k | 5.68 |
|
|
| Neuphoria Therapeutics (NEUP) | 0.0 | $116k | NEW | 30k | 3.88 |
|
| Clover Health Investments Com Cl A (CLOV) | 0.0 | $114k | 48k | 2.35 |
|
|
| Zentalis Pharmaceuticals (ZNTL) | 0.0 | $108k | +60% | 80k | 1.35 |
|
| Bioatla (BCAB) | 0.0 | $104k | NEW | 183k | 0.57 |
|
| Sab Biotherapeutics Com New (SABS) | 0.0 | $99k | +75% | 26k | 3.74 |
|
| Solidion Technology Com New Call Option (STI) | 0.0 | $96k | 14k | 7.09 |
|
|
| Fibrogen Com New (KYNB) | 0.0 | $92k | NEW | 11k | 8.78 |
|
| Rezolute Com New (RZLT) | 0.0 | $91k | -95% | 39k | 2.36 |
|
| Neumora Therapeutics (NMRA) | 0.0 | $91k | NEW | 51k | 1.79 |
|
| Pliant Therapeutics (PLRX) | 0.0 | $90k | NEW | 74k | 1.22 |
|
| Mei Pharma (LITS) | 0.0 | $89k | -76% | 67k | 1.32 |
|
| Ocuphire Pharma (IRD) | 0.0 | $80k | NEW | 40k | 2.01 |
|
| Kala Bio Com New (KALA) | 0.0 | $79k | 142k | 0.56 |
|
|
| Veru Com New (VERU) | 0.0 | $75k | NEW | 35k | 2.14 |
|
| Q32 Bio (QTTB) | 0.0 | $66k | NEW | 20k | 3.32 |
|
| Mereo Biopharma Group Spon Ads (MREO) | 0.0 | $63k | NEW | 150k | 0.42 |
|
| Biomea Fusion (BMEA) | 0.0 | $54k | NEW | 43k | 1.24 |
|
| A Spac Iii Acquisition Corp Right 01/02/2026 (ASPCR) | 0.0 | $41k | 215k | 0.19 |
|
|
| Atyr Pharma Com New (ATYR) | 0.0 | $40k | -89% | 51k | 0.78 |
|
| Proqr Thrapeutics N V Shs Euro (PRQR) | 0.0 | $20k | 10k | 2.02 |
|
|
| INVO Fertility (IVF) | 0.0 | $20k | NEW | 27k | 0.75 |
|
| Io Biotech (IOBT) | 0.0 | $15k | NEW | 25k | 0.61 |
|
| Coherus Biosciences (CHRS) | 0.0 | $15k | 10k | 1.42 |
|
Past Filings by ADAR1 Capital Management
SEC 13F filings are viewable for ADAR1 Capital Management going back to 2023
- ADAR1 Capital Management 2025 Q4 restated filed Feb. 18, 2026
- ADAR1 Capital Management 2025 Q4 filed Feb. 17, 2026
- ADAR1 Capital Management 2025 Q3 filed Nov. 14, 2025
- ADAR1 Capital Management 2025 Q2 filed Aug. 14, 2025
- ADAR1 Capital Management 2025 Q1 filed May 15, 2025
- ADAR1 Capital Management 2024 Q4 filed Feb. 13, 2025
- ADAR1 Capital Management 2024 Q3 filed Nov. 14, 2024
- ADAR1 Capital Management 2024 Q2 filed Aug. 13, 2024
- ADAR1 Capital Management 2024 Q1 filed May 15, 2024
- ADAR1 Capital Management 2023 Q4 filed Feb. 14, 2024